13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • DYNAMIC

    Acronym: 

    DYNAMIC

    ACTRN/NCT /ethics: 

    ACTRN12615000381583

    Scientific title: 

    Circulating tumour DNA (ctDNA) analysis informing adjuvant chemotherapy in Stage II Colon Cancer

    Summary of trial and patient characteristics

    Cancer Type Bowel and colon
    Trial Type Treatment
    Phase All phases Tumour Stream Colon, Rectum
    Age Range 18 years and older Cancer Stage Locally Recurrent or Locally Advanced
    Sex Both Anticipated Start Date 2015-05-01
    Molecular Target Anticipated End Date 2020-01-01
    Cancer Type Bowel and colon
    Trial Type Treatment
    Phase All phases
    Age Range 18 years and older
    Sex Both
    Molecular Target
    Tumour Stream Colon, Rectum
    Cancer Stage Locally Recurrent or Locally Advanced
    Anticipated Start Date 2015-05-01
    Anticipated End Date 2020-01-01

    Trial Summary

    This study will determine the effect of the use of circulating tumour DNA (ctDNA) to guide adjuvant chemotherapy on recurrence-free survival in stage II colon or rectal cancer patients

    Lay Summary

    Circulating tumour DNA (ctDNA) analysis informing adjuvant chemotherapy in Stage II Colon Cancer

    Sponsor / Cooperative group

    Walter and Eliza Hall Institute

    Participating Hospitals

    Hospital Clinical Trial Coordinator Email Phone Principal Investigator Recruitment Status
    Flinders Medical Centre Alex Scott-Hoy alex.scott-hoy@sa.gov.au 08 8204 4830 Chris Karapetis Recruiting